Early hepatitis C RNA testing is most cost effective strategy

February 2009
Nursing Standard;2/18/2009, Vol. 23 Issue 24, p16
Trade Publication
The article reports that researchers in France have found that a strategy based on early hepatitis C RNA testing shortens the time healthcare workers exposed to the hepatitis C virus must wait for the results of their virus status, is reasonably cost effective, and results in a lower risk of progression to chronic hepatitis C.


Related Articles

  • Broadened HCV screening recommended.  // PharmacoEconomics & Outcomes News;3/31/2012, Issue 650, p7 

    The article reports on a study which found that broadened screening of the whole U.S. population for hepatitis C virus (HCV) would be cost effective compared with the current practice of screening only high-risk individuals.

  • Hepatitis C screening -- cost effective in MSM in the US?  // PharmacoEconomics & Outcomes News;4/28/2012, Issue 652, p5 

    The article discusses research on the cost effectiveness of hepatitis C screening in HIV-infected men who have sex with men (MSM), referencing a study by B. P. Linas and colleagues published on the April 4, 2012 issue of "Clinical Infectious Diseases."

  • Routine antenatal screening for hepatitis C cost effective.  // PharmacoEconomics & Outcomes News;Jun2015, Vol. 729 Issue 1, p26 

    The article discusses research on the cost effectiveness of routine antenatal screening for hepatitis C, referencing a study by N. Selvapatt et al and published in the May 27, 2015 issue of the "Journal of Hepatology."

  • Identifying cost-effective strategies for hepatitis C testing.  // PharmacoEconomics & Outcomes News;Jul2015, Vol. 732 Issue 1, p21 

    The article reports on the cost effective strategies for testing current hepatitis C virus (HCV) infection through the antibody to HCV (HCVAb) in venipuncture blood, and quantitative nucleic acid test (NAT) for HCV RNA with similar viraemia sensitivity.

  • Spontaneous clearance of hepatitis C virus during pregnancy. Clohessy, Penelope; Polis, Suzanne; Post, Jeffrey // Obstetric Medicine (1753-495X);Mar2013, Vol. 6 Issue 1, p28 

    Spontaneous clearance of hepatitis C virus (HCV) is expected to be unlikely in pregnancy due to the relative immunosuppression and increase in viraemia that occurs. We report the first case of spontaneous clearance of hepatitis C virus (HCV) occurring in pregnancy.

  • HCV Screening to Enable Early Treatment of Hepatitis C: A Mathematical Model to Analyse Costs and Outcomes in Two Populations. Tramarin, A.; Gennaro, N.; Compostella, F. A.; Gallo, C.; Bonga, L. J. Wendelaar; Postma, M. J. // Current Pharmaceutical Design;Jun2008, Vol. 14 Issue 17, p1655 

    Early treatment of acute hepatitis C virus (HCV) infections reflects a new clinical paradigm and a significant option to reduce the socioeconomic burden of HCV. Therefore, this approach seems suitable as a new strategy to face HCV and prevent end stage liver diseases and premature deaths due to...

  • The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy. Mesquita, Fabio; Santos, Melina Erica; Benzaken, Adele; Corrêa, Renato Girade; Cattapan, Elisa; Sereno, Leandro Soares; Moscoso Naveira, Marcelo Contardo // BMC Public Health;11/2/2016, Vol. 16 Issue 1, p1 

    Background: Hepatitis C affects over 185 million people around the world. This silent disease is responsible for up to 700,000 deaths per year. Despite the scientific revolution in diagnosis and treatment, hepatitis C control remains a huge challenge due to the cost of effective medications. In...

  • Hepatitis C: The silent killer of infected patients and... Petersen, Carolyn // Managed Healthcare;Jul98, Vol. 8 Issue 7, p45 

    Provides information on hepatitis C virus (HCV) which is the third infectious disease. How hepatitis C is transmitted; Reason relatively few people in the United States are aware of HCV; Eight groups which should be tested based on the epidemiology of the virus; How HCV can be treated. INSET:...

  • Transfusions to tattoos--the danger of hepatitis C. Albrecht, Jeffrey H.; Jensen, Donald M. // Patient Care;7/15/1996, Vol. 30 Issue 12, p112 

    Presents recommendations for physicians on screening their patients for hepatitis C infection. Clinical characteristics; Genetical information on the hepatitis C virus (HCV); People most at risk; Transaminase findings; Antibody testing; Use of RNA testing in research settings; Use of biopsy in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics